Clinical Scorecard: Can Gene Scores Help Detect Sepsis?
At a Glance
| Category | Detail |
|---|---|
| Condition | Sepsis |
| Key Mechanisms | Rapid gene expression-based blood test measuring PLA2G7 and PLAC8. |
| Target Population | Adults admitted to ICU with suspected sepsis. |
| Care Setting | Intensive Care Unit (ICU) |
Key Highlights
- Gene expression assay achieved AUC of 0.84 for differentiating sepsis from noninfectious critical illness.
- Positive predictive value for sepsis in Band 4 was 92%; sensitivity was 79%.
- Diagnostic performance superior to CRP (0.75) and similar to PCT (0.80).
- No association found between gene score and disease severity or mortality.
- Initial clinical assessment and gene score were independent predictors of sepsis.
Guideline-Based Recommendations
Diagnosis
- Utilize gene expression score to aid in distinguishing sepsis from sterile inflammation.
Management
- Consider gene score results in conjunction with clinical assessment for sepsis management.
Monitoring & Follow-up
- Monitor patients with low gene scores for absence of sepsis diagnosis.
Risks
- Limitations include lack of data on prior antibiotic exposure and reliance on clinical adjudication.
Patient & Prescribing Data
353 adults suspected of sepsis in ICU.
Gene score can refine diagnostic accuracy and guide treatment decisions.
Clinical Best Practices
- Incorporate gene expression testing in sepsis protocols.
- Use in conjunction with clinical judgment and other biomarkers.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
